Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases

Simple item page
dc.contributor.authorRamesha, KN
dc.contributor.authorKuruvilla, A
dc.contributor.authorSarma, PS
dc.contributor.authorRadhakrishnan, VV
dc.date.accessioned2017-03-10T03:25:58Z
dc.date.available2017-03-10T03:25:58Z
dc.date.issued2010
dc.description.abstractObjectives: To study the electroclinical and histopathologic profile of idiopathic inflammatory myositis (IIM) with reference to prognosis and survival rate. Materials and Methods: Diagnosis of IIM was based on the Bohan and Peter criteria. Patients who improved and those whose condition worsened or who expired due to IIM per se at last follow-up were classified to have favorable and poor outcomes, respectively. Fishers exact test was used for univariate analysis of prognostic factors. Results: The study cohort consisted of consecutive 68 patients with IIM. The mean age at diagnosis was 36.5 years and females constituted 71%. Of these patients, 62% had definite IIM, 49% had polymyositis, 20% had dermatomyositis, and 29% had overlap syndrome. The mean follow-up period was 5.4 years. Prednisolone alone was used in 55 (80%), and azathioprine (1-3 mg/kg/day) alone in 12 (17.6%) as the initial treatment. Relapse of IIM with drug withdrawal was seen in 15 patients (22%); 70% had favorable outcome and 16% had expired. The treatment delay of %6 months (P = 0.001), absence of cardiac or lung involvement (P < 0.001), and positive biopsy (P = 0.033) were predictive of a favorable prognosis in the univariate analysis. In multivariate analysis, only the duration of illness of %6 months (P = 0.008) and the absence of cardiac or lung involvement (P = 0.001) predicted the favorable outcome at last follow-up. Cumulative survival rate was 95% at 1 year, 86% at the 5th year, and 80% at the 10th year. Conclusions: Approximately, two-thirds of the patients showed good electroclinical and histopathologic correlations and an equal number improved with treatment. The treatment delay (>= 6 months), presence of cardiac or pulmonary involvements, and negative muscle biopsy are bad prognostic factors.
dc.identifier.citation13 ,4;250-256en_US
dc.identifier.uri10.4103/0972-2327.74190
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/9477
dc.publisherANNALS OF INDIAN ACADEMY OF NEUROLOGY
dc.subjectNeurosciences & Neurology
dc.titleClinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases
Files
Collections
Journal Articles